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1. Introduction
   Chronic obstructive pulmonary disease (COPD) is a major 
cause of morbidity and mortality worldwide. It is among 
top 10 global contributors to the global burden of disease 
as measured by disability-adjusted life years[1]. The global 
burden of disease study has projected that COPD, which 
ranked sixth as the cause of death in 1990, will become the 
third leading cause of death worldwide by 2020, thus, among 
all major chronic diseases, COPD is the only disease that 
shows rising mortality[2-4].
   Acute exacerbation of COPD (AECOPD) is largely 
responsible for morbidity and mortality associated with 
the disease[5]. An exacerbation of COPD is an event in the 
natural course of the disease characterized by a change 
in the patient’s baseline dyspnea, cough and/or sputum 
beyond day-to-day variability sufficient to warrant a 
change in managemen[6]. Noninvasive positive pressure 
ventilation (NIPPV) is claimed to be safe and effective 
modality in treating patients with AECOPD[5]. It helps in 
preventing endotracheal intubation in acute respiratory 
failure secondary to COPD as compare to other causes[7]. 
However, NIPPV is not successful in all cases of AECOPD, 
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with a failure rate of 66% in an Indian study and 18.18%, 
50% and 23% in different western studies[8-11]. One of the 
retrospective studies done in Aga Khan University hospital 
showed that coexisting sepsis and hypercapneic acute 
respiratory failure have high hospital mortality on NIPPV 
with failure rate of 23.5%[12].
   Out of 250 patients enrolled in the study, 29 (24.16%) 
patients aged 60-75 years had to undergo endotracheal 
intubation. Patients with oxygen saturation in the range 
82%-86% at the time of admission, 75 (50%) of these had 
poor prognosis. Patients with pH range 7.20-7.26 carry poor 
prognosis and 100 (66.66%) required endotracheal intubation. 
Out of 100 patients with pedal edema, 70 (70%) had to 
undergo endotracheal intubation[8].
   The aim of the study is to determine the factors leading to 
poor outcome in patients with AECOPD who are treated with 
NIPPV. So that protocol could be developed for such patients 
and endotracheal intubation could be applied without giving 
trial of NIPPV, which fasten recovery and decrease the 
morbidity.
 
2. Materials and methods
2.1. Place of study
   This cross sectional study was conducted from May 2012 to 
November 2012 in Department of Chest Medicine in Jinnah 
Postgraduate Medical Centre. Patients with the diagnosis 
of AECOPD as defined in the operational definition, 
meeting the inclusion criteria were selected from the ER 
department, Jinnah Postgraduate Medical Centre, Karachi. 
Permission from ethical committee of Jinnah Postgraduate 
Medical Centre and written consent from the patients 
was taken. At the time of admission age was inquired BP, 
respiratory rateand oxygen saturation will be noted and 
pedal edema was assessed and investigations were sent 
for pH assessment. NIPPV using BiPAP (vision Respironics 
INC. USA. BiPAP S/T 30) was applied in spontaneous mode 
by the help of oronasal mask with head straps to minimize 
the leak. A single, more than 4 years’ experienced operator, 
was applied BiPAP to control operator bias and researcher 
himself monitored the response. Calibration of the machine 
was done to control instrument bias. Therapy was initiated 
with an inspiratory positive airway pressure (10 cm H2O) and 
expiratory positive airway pressure (5 cm H2O) and it was 
optimized according to patient’s comfort and blood pressure.
   Patient’s response was monitored clinically at 30 min, 1 h 
and at the end of 2 h. Presence of respiratory rate (less than 
12/min), systolic blood pressure < 90 mmHg, GCS < 13 and 
PaO2≤65, pH < 7.2 and heart rate >140 bpm was taken as 
poor outcome and the patient was underwent endotracheal 
intubation. This information along with the demographics 
was entered into the proforma attached as annexure. 
Required sample size was 195 patients calculated by using 
WHO sample size determination software with 24.16% COPD 
treated with non-invasive mechanical ventilation patients 
and 95% confidence interval and 6% level of precision[8]. 
Sample was collected by non-probability purposive 
sampling. Age between 40-80 years  and duration of COPD 
more than 6 months were defined as inclusion criteria 
while cardiac and respiratory arrest, upper gastrointestinal 
bleed, comatose patients, hypotension even with ionotropes 
support, arrhythmias, poor gag reflex, hyponatraemia serum 
sodium <120 mmol/lit and patients with pneumothorax were 
exluded from study. 
2.2. Data analysis procedure
   Data was entered and analyzed through SPSS version 15. 
Continuous variables like age, systolic blood pressure, heart 
rate, respiratory rate, GCS, pH and SaO2 were expressed 
as mean依SD. Whereas categorical variables like poor 
outcome, older age group (age more than 60 years), gender, 
pedal edema and academia were presented in frequencies 
and percentages. Effect modifiers were controlled through 
stratification of age and gender to see the effect of these on 
outcomes by applying Chi square test and P≤0.05 was taken 
as significant.
 
3. Results
   A total of 195 diagnosed case of AECOPD were included in 
this study. Out of 195 patients, 116 (59.5%) were male and 79 
(40.5%) were female with 1.5:1 male to female ratio.
   The average age of the patients was 61.9依9.3 years. 
Minimum age was 40 years and maximum age was 78 years. 
Most of the patients had age > 60 years [111 (56.9%)]. 
   After 2 h of NIPPV, mean systolic blood pressure was (121.9
依22.5) mmHg and mean respiratory rate was 20.2依4.6, heart 
rate was 120依15.3, pH was 7.25依0.09, GCS was 10.4依2.2 and 
mean SaO2 was 87.5依7.9 (Table 1).
 
Table 1
Characteristics of patients with an AECOPD after 2 h of treatment 
(n=195).
Parameters Mean依SD
SBP 121.9依22.5
Respiratory rate 
(Breaths/min)
20.2依4.6
GCS 10.4依2.2
pH  7.25依0.09
SaO2 87.5依7.9
Heart rate 
(Beats/min)
120.0依15.3
SBP=Systolic blood pressure; GCS=Glasgow coma scale.
   NIPPV was successful in 151 (77.4%) cases and 44 (22.6%) 
cases were underwent endotracheal intubation (poor 
outcomes). 
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   Stratification was done with regards to gender and age 
to see the effect of these on outcomes. Poor outcomes of 
NIPPV were significantly high in male [33 (28.4%)], and low 
in female [11 (13.9%)] (P=0.028). While 29 (24.16%) patients 
of age > 60 years had to undergo endotracheal intubation 
(P=0.026).
   Patients with oxygen saturation were in the range 82%-
86%. About 38 (44.7%) of these had poor prognosis. Patients 
with pH range 7.20-7.26, 40 (55.6%) of these required 
endotracheal intubation while 43 (66.2%) with pedal edema 
had to undergo endotracheal intubation (Table 2 ).
Table 2
Other factors leading to poor outcomes (n=195). 
Factors Number of cases Poor outcomes Percent
SaO2 (82%-86%) 85 38 44.7%
Acedemia (pH 7.2 - 7.26) 72 40 55.6%
Pedal edema          65 43 66.2%
4. Discussion
   The use of noninvasive ventilation (NIV) in the 
management of COPD is now supported by a number of 
randomized controlled trials[13-17]. It has been shown to 
reduce intubation rates, mortality, and length of hospital 
stay[13-17]. It has the advantage that it can be applied 
intermittently, avoids the need for sedation, and allows the 
patient to eat, drink, and speak. The incidence of nosocomial 
pneumonia during NIV is lower than in intubated patients. 
However, NIV is not successful in all cases of acute on 
chronic respiratory failures owing to COPD, with reported 
failure rates of 7%-50%[16]. There has also been concern that 
NIV may delay intubation, leading to a worse outcome[18,19].
   In this study, NIPPV was successful in 77.4% cases and 
22.6% cases were underwent endotracheal intubation (poor 
outcomes) which is similar to reintubation rates described 
elsewhere from India and the European-American 
countries[20-23]. There is little doubt on the efficacy of NIV 
in AECOPD and cardiogenic pulmonary edema[8,24]. A study 
from India reported the success rate of NIPPV was 87.5% 
for AECOPD[7]. One of the retrospective studies done in Aga 
Khan University hospital showed that coexisting sepsis and 
hypercapneic acute respiratory failure had high hospital 
mortality on NIPPV with failure rate of 23.5%[12]. However, 
NIPPV is not successful in all cases of acute exacerbation 
of COPD, with a failure rate of 66% in an Indian study and 
18.18%, 50% and 23% in different western studies[8-11].
   In this study, pedal edema has been shown to predict 
death or patient requiring endotracheal intubation owing to 
acute exacerbation of COPD; 66.2% of the cases with pedal 
edema had to undergo endotracheal intubation. The evidence 
for the use of NIV remains strongest in patients with 
hypercapnic acute respiratory failure due to exacerbations 
of COPD and cardiogenic pulmonary edema[8,24]. Shameem et 
al. reported that out of 100 patients with pedal edema 70% 
required endotracheal intubation[8].
   Acidosis was also strong indicator of endotracheal 
intubation owing to acute exacerbation of COPD[10,14]. 
In this study, patients with pH range 7.20-7.26 carry 
poor prognosis and 55.6% of these required endotracheal 
intubation. Ambrosino et al. found that patients in whom 
NIV treatment failed were significantly more academic at 
baseline than those successfully treated[18]. Brochard et 
al. found that success was less likely with a lower starting 
pH[17]. Shameem et al. also reported the similar results; they 
reported that patients with pH range 7.20-7.26 carried poor 
outcome and 66.7% required endotracheal intubation[8].
   Oxygen saturation (SaO2) at the time of admission can 
predict outcome of the patient. As in this study, patients 
oxygen saturation were in the range of 82%-86%; 44.7% of 
these had poor prognosis. Shameem et al. also reported that 
patients with oxygen saturation were in the range of 82%-
86% at the time of admission; 75 (50%) of these had poor 
prognosis[8].
   Stratification was done with regards to gender and age 
to see the effect of these on outcomes. Poor outcomes of 
NIPPV were significantly high in male 33 (28.4%) (P=0.028). 
While 29 (24.16%) patients of age > 60 years had to 
undergo endotracheal intubation (P=0.026). These facts are 
consistent with the observations of other authors[10,25,26]. 
Shameem et al. studied 250 patients in the study; 24.16% 
patients of age 60-75 years had to undergo endotracheal 
intubation.
   The results of this study suggest, management of patients 
with acute exacerbation of COPD, in addition to medical 
therapy, should include NIV if they present with moderate 
respiratory acidosis (pH< 7.35). Patients who fail to respond 
or have contraindication to NIV should be evaluated for 
endotracheal intubation and mechanical ventilation. NIV is 
a welcome advancement in the management of respiratory 
failure. In selected patients with acute exacerbations of 
chronic obstructive pulmonary disease, NIV can reduce the 
need for endotracheal intubation, the length of the hospital 
stay, and the in-hospital mortality rate.
   In this study, NIPPV was successful in 77.4% cases and 
22.6% cases were underwent endotracheal intubation (poor 
outcomes). Pedal edema was the most common factor 
leading to poor outcomes while age > 60 years was the 
least common factor, 66.2% and 24.2% respectively. While 
patients with pH range 7.20-7.26, 55.6% of these required 
endotracheal intubation. Other factor was oxygen saturation 
(82%-86%).In conclusion, this study demonstrates that 
NIPPV is an effective modality in preventing endotracheal 
intubation due to COPD. 
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